PTK2 and lung carcinoma: Moreover, FAK has been demonstrated to be involved in the regulation of nuclear deformity and cellular senescence; indeed, Chuang et al. [39] demonstrated that FAK pharmacological inhibition by PF-573228 treatment induced a senescence-like pattern in lung cancer cells, leading to a reduction in lamin A/C expression and to p53 up-regulation.